A Phase III Study of Radical Radiotherapy with or without Gemcitabine in Patients with T1-2 N0-1 M0 Non-Small Cell Lung Cancer.
Phase of Trial: Phase III
Latest Information Update: 16 Dec 2015
At a glance
- Drugs Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms GRIN
- 01 Sep 2012 Status changed from completed to discontinued, as reported in Lung Cancer.
- 01 Sep 2012 Results published in the Lung Cancer.
- 10 Jun 2010 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History